cognitive cybersecurity intelligence
Jan. 6, 2023 — The highly anticipated Alzheimer’s drug lecanemab was granted accelerated approval status this afternoon by the FDA, offering hope where there has been little for patients and their families affected by the devastating disease.More than 6 million people in the U.S. live with…
Source: www.webmd.com – Read more
Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.
Brockton hospital hit by cybersecurity incident, services affected wcvb.com
TrojAI has extended its platform for securing artificial intelligence (AI) applications, tools and platforms to now include a red teaming capability that is performed by
Register Now Panelists: Rodolphe Barrangou, PhD North Carolina State University View Bio Panelist Rodolphe Barrangou, PhD Rodolphe Barrangou, PhD, is the T. R. Klaenhammer Distinguished
Emerging Cybersecurity Threats: Safeguarding Your Organization in a Rapidly Evolving Landscape JD Supra
